{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:22:13Z","timestamp":1792858933394,"version":"4.5.0"},"reference-count":83,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"unspecified","delay-in-days":32,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017239","name":"BeiGene","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017239","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2021,11,2]]},"DOI":"10.1080\/17512433.2021.1978288","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T08:37:04Z","timestamp":1631003824000},"page":"1329-1344","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":66,"title":["Clinical pharmacology and PK\/PD translation of the second-generation Bruton\u2019s tyrosine kinase inhibitor, zanubrutinib"],"prefix":"10.1080","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9759-5017","authenticated-orcid":false,"given":"Constantine S.","family":"Tam","sequence":"first","affiliation":[{"name":"Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia"},{"name":"Department of Haematology, St Vincent\u2019s Hospital, Fitzroy, VIC, Australia"},{"name":"Department of Haematology, University of Melbourne, Parkville, VIC, Australia"},{"name":"Department of Haematology, Royal Melbourne Hospital, Parkville, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying C.","family":"Ou","sequence":"additional","affiliation":[{"name":"Sr. Director, Clinical Pharmacology, BeiGene USA Inc., San Mateo, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Trotman","sequence":"additional","affiliation":[{"name":"Department of Haematology, Concord Repatriation Hospital, Concord, NSW, Australia"},{"name":"Department of Haematology, The University of Sydney, Concord, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Opat","sequence":"additional","affiliation":[{"name":"Director, Clinical Haematology, Monash Health, Clayton, VIC, Australia"},{"name":"Director, Clinical Haematology, Monash University, Clayton, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2004.04.008"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1038\/nri955"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1038\/nri3487"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2013.09.001"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-123331"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00224-5"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3703"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020004074"},{"key":"cit0009","volume-title":"Brukinsa\u00ae [package insert]","year":"2019"},{"key":"cit0010","unstructured":"BeiGene Press Release. BeiGene announces the approval of BRUKINSA\n                      TM\n                      (Zanubrutinib) in China for patients with relapsed\/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma and relapsed\/refractory mantle cell lymphoma 2020. [cited 2021 Aug 1]. Available from: http:\/\/ir.beigene.com\/news-releases\/news-release-details\/beigene-announces-approval-brukinsatm-zanubrutinib-china]"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001160"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00884-4"},{"key":"cit0013","unstructured":"BeiGene Press release. Health Canada approves brukinsa\u00ae (zanubrutinib) for the treatment of waldenstrom\u2019s macroglobulinemia. 2021. [cited 2021 Aug 1]. Available from https:\/\/ir.beigene.com\/news-releases\/news-release-details\/health-canada-approves-brukinsar-zanubrutinib-treatment]."},{"key":"cit0014","unstructured":"Hillmen P, Eichhorst B, Brown JR, et al. First interim analysis of ALPINE study: results of a phase 3 randomized study of zanubrutinib vs ibrutinib in patients with relapsed\/refractory chronic lymphocytic leukemia\/small lymphocytic lymphoma. EHA 2021. LB 1900."},{"key":"cit0015","unstructured":"US Food and Drug Administration Center for Drug Evaluation and Research (Ibrutinib ImbruvicaTM). Application number 20552Orig2s000. [cited 2021 Aug 1]. Available at https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/205552Orig2s000ClinPharmR.pdf]"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-548610"},{"key":"cit0017","volume-title":"Imbruvica\u00ae (ibrutinib) [package insert]","year":"2015"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00687"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.117.242909"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-547869"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-10-879429"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-127102"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817073"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-109973"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12605"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12787"},{"key":"cit0027","volume-title":"Brukinsa\u00aeProduct Monograph","author":"Canada H","year":"2021"},{"key":"cit0028","volume-title":"Calquence\u00ae [package insert]","year":"2019"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509981"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.7906"},{"key":"cit0031","doi-asserted-by":"crossref","unstructured":"DImopoulos M, Opat S, Lee H-P, et al. Major responses in MYD88 wildtype (MYD88WT) Waldenstrom macroglobulinemia (WM) patients treated with Bruton tyrosine kinase (BTK) inhibitor zanubrutinib (BGB-3111) 2019 [cited 2021 Aug 1]. Available from: https:\/\/library.ehaweb.org\/eha\/2019\/24th\/266287\/meletios.a.dimopoulos.major.responses.in.myd88.wildtype.%28myd88wt%29.waldenstrm.html].","DOI":"10.1002\/j.2572-9241.2019.tb00086.x"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3505"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215637"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003715"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30354-1"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199405263302104"},{"key":"cit0037","unstructured":"US Food and Drug Administration Center for Drug Evaluation and Research. Application number 213217Orig1s00 multi-discipline review package. 2019 [Bruinksa] [cited 2021 Aug 1]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2019\/213217Orig1s000MultidisciplineR.pdf]."},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-015-2708-9"},{"key":"cit0039","unstructured":"US Food and Drug Administration Center for Drug Evaluation and Research. Approval package for application number 210259Orig1S006, 210259Orig1s007 (CALQUENCE capsules). [cited 2021 Aug 1]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2019\/210259Orig1s006,%20s007.pdf]."},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.118.084459"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.114.060061"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000155"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-018-3546-3"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-05-647834"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12948"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1719097"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-019-04015-w"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-014-2617-3"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0725-7"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1086\/598327"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.156"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1251592"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-12-737346"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.1588.1588"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.73"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14707"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12408"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006844"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-017-3471-x"},{"issue":"5","key":"cit0060","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/cts.12779","volume":"13","author":"Mu S","year":"2020","journal-title":"Clin Transl Sci"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.247"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-583294"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000562920.26603.5b"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1375110"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.630942"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1996.0188"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.1929961"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1142"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(98)70471-3"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00325.2015"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13651"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017011999"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2018-0163"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.306130"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000640"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-604272"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.090126"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.049210"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12333"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2667"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key339"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1002\/hon.55_2630"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006449"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2021.1978288","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T19:18:24Z","timestamp":1725736704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2021.1978288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":83,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,2]]}},"alternative-id":["10.1080\/17512433.2021.1978288"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2021.1978288","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-06-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}